ResMed Inc. |
Market Cap (16-Aug) $46,461,558,784 (13th) |
Close (30-Jun) $32.81 |
Volume (30-Jun) 1,098,777 |
Shortsold (10-Aug) 2,676,736 (0.45%) (321st) |
|
52w High $44.92 |
52w Low $25.50 |
P/E 18.48 |
EPS 1.48 |
[ARTICLE] ResMed downplays Ozempic disruption fears as sales beat forecasts
A news article has been posted about ResMed Inc. on the AFR. The article was published around , on 25 October 2024 at 5:20pm.
Chief executive Mick Farrell says the company has only scratched the service in global demand for sleeping disorder devices.
Read ArticleRMD was $32.81 at the close of trade on 30 June 2023
| Recent Articles about ASX:RMD | |
|---|---|
| 8-Aug | Notification of dividend / distribution Appendix 3A.1 - Market Index
company-announcements.afr.com |
| 7-Aug | ResMed ASX Deferral of Conversions Announcement - August 2026
company-announcements.afr.com |
| 7-Aug | Resmed Inc. Announces Results for the Fourth Quarter of Fiscal ...
company-announcements.afr.com |
| 7-Aug | DJW NTA - AFR
company-announcements.afr.com |
| 31-Jul | 30 July 2026 The Manager ASX Market Announcements ASX ... - AFR
company-announcements.afr.com |
| 24-Jul | DJW Appendix 4E and media release 30 June 2026 - AFR
company-announcements.afr.com |
| 10-Jul | Australian United Investment Company Limited - AFR
company-announcements.afr.com |
| 8-Jul | ResMed Inc. - AFR
company-announcements.afr.com |
| 7-Jul | FORM 4 - AFR
company-announcements.afr.com |
| 3-Jul | AMH NTA - AFR
company-announcements.afr.com |
| Tracked |
Find all articles about ResMed Inc., including others on the AFR, on the media page.
You must be logged in to post a reply.